|
| Press Releases |
|
 |
|
| Wednesday, March 23, 2022 |
|
|
Alset International Limited establishes Alset Mining Pte. Ltd. to embark on cryptocurrency mining activities |
| Singapore Exchange-listed Alset International Limited (SGX Stock Code: 40V) ("Alset", the "Company" or together with its subsidiaries, the "Group) wishes to announce that the Company has plans to embark on cryptocurrency mining business through its subsidiary Alset Mining Pte. Ltd. ("Alset Mining"). more info >> |
|
| Monday, February 21, 2022 |
|
|
Alset Capital Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option |
| Alset Capital Acquisition Corp. (the "Company") announced on February 3, 2022 the closing of its initial public offering of 7,500,000 units at $10.00 per unit (the "Offering"). more info >> |
|
| Monday, October 5, 2020 |
|
|
Impact BioMedical to Begin Efficacy Testing Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc. |
| Document Security Systems, Inc. today announced its wholly owned subsidiary Impact BioMedical, Inc. ("Impact BioMedical") has formed a new wholly owned subsidiary, Innate Immune, Inc. ("Innate Immune"), to initiate efficacy testing of a pancoronavirus vaccine, a special type of vaccine designed to protect against multiple coronaviruses. more info >> |
|
| Friday, September 18, 2020 |
|
|
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance |
| Document Security Systems, Inc. (NYSE American: DSS) today announced its wholly owned subsidiary Impact BioMedical, Inc., through its subsidiary Global BioLife, Inc., completed efficacy testing of its proprietary 3F Antiviral Biofragrance at a biosafety level 3 containment facility at an independent university. more info >> |
|
| Friday, July 31, 2020 |
|
|
Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly-owned subsidiary Impact Biomedical Inc. ("Impact"), announced today the initiation of Quantum, their research program designed to solve the impending pharmaceutical patent cliff threat. more info >> |
|
| Wednesday, June 24, 2020 |
|
|
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that they proved in vitro success of Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing. more info >> |
|
| Wednesday, June 17, 2020 |
|
|
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that their COVID-19 research with Global Research and Discovery Group Sciences ("GRDG"), conducted in collaboration with Harvard Medical School and Vilotos Pharmaceutical, Inc. ("Vilotos"), was published in the peer-reviewed scientific journal Molecules on June 11, 2020. more info >> |
|
| Monday, June 1, 2020 |
|
|
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary, Impact Biomedical Inc., would like to update its stakeholders on its suite of antiviral and medical technologies. more info >> |
|
| Friday, April 24, 2020 |
|
|
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts |
| SGX-listed Singapore eDevelopment Ltd's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc., announced recently that their suite of antiviral and medical technologies, co-owned with its partners, is valued at USD 592 Million (SGD 841 Million). Impact Biomedical's effective ownership of 64.53% in the suite of technologies equates to a value of USD 382 Million (SGD 542 Million). more info >> |
|
| Wednesday, March 18, 2020 |
|
|
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak |
| Singapore Exchange-listed Singapore eDevelopment Limited has announced that its wholly-owned U.S. biomedical subsidiary, Impact BioMedical, Inc., has, through its scientific research partner, GRDG Sciences, LLC. ("GRDG"), recently conducted molecular docking studies, utilizing advanced computational models, which indicate Linebacker and Equivir successfully inhibit infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Revolutionary Blockchain-based Dancing Platform, DANSA to Be Launched Soon
Aug 10, 2022 21:00: JST
|
|
|
Revolutionary Blockchain-based Dancing Platform, DANSA to Be Launched Soon
Aug 10, 2022 21:00 HKT/SGT
|
|
|
CleverTap Raises US$105M in Series D Funding Round Led by CDPQ
Aug 10, 2022 21:00 HKT/SGT
|
|
|
CleverTap Raises US$105M in Series D Funding Round Led by CDPQ
Aug 10, 2022 21:00 HKT/SGT
|
|
|
创科实业于二零二二年上半年创下骄人业绩
Aug 10, 2022 19:27 HKT/SGT
|
|
|
創科實業於二零二二年上半年創下驕人業績
Aug 10, 2022 19:26 HKT/SGT
|
|
|
TTI Delivers Strong 2022 First Half Results
Aug 10, 2022 19:25 HKT/SGT
|
|
|
TOYOTA、9月 生産計画について発表
Aug 10, 2022 17:00: JST
|
|
|
Honda、2022年度第1四半期決算および通期業績見通しを発表
Aug 10, 2022 15:30: JST
|
|
|
三菱自動車、MIRAI-LABO、電動車の使用済みバッテリーを用いた自律型街路灯の開発検討を開始
Aug 10, 2022 15:00: JST
|
|
|
《滨海宁波·扬帆世界》邓蓓佳独家专访周莉莉：香港当好超级联系人 联合国秘书长特使建言献策
Aug 10, 2022 13:59 HKT/SGT
|
|
|
《濱海寧波·揚帆世界》鄧蓓佳獨家專訪周莉莉：香港當好超級聯繫人 聯合國秘書長特使建言獻策
Aug 10, 2022 13:58 HKT/SGT
|
|
|
Bintai Kinden to Market O&G Equipment in Indonesia
Aug 10, 2022 13:00 HKT/SGT
|
|
|
Society Pass backed Thoughtful Media Group Announces New CEO and Vision to be the Leader in Digital and Social Commerce in SEA
Aug 10, 2022 12:00 HKT/SGT
|
|
|
India's top BFSI experts Unite to Reshape India's Banking Landscape at #TresconBFSI
Aug 9, 2022 20:42 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
